MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer
Ticker:
MAIA
Exchange:
NYSE
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Illinois
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Oncology
Lead Product in Development:
THIO
Development Phase of Primary Product:
Phase II
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
